OnabotulinumtoxinA exhibits greater efficacy compared to purified botulinum neurotoxin type A (BoNT/A-150 kDa) in peripheral pain models

Autor:	Greg Nicholson, Amy Brideau-Andersen, Ron S. Broide, Sudhakar R. Subramaniam, Brian B. Cai
Rok vydání:	2021
Předmět:	Peripheral pain Botulinum Neurotoxin Type A business.industry Medicine Pharmacology Toxicology business
Zdroj:	Toxicon. 190:S70
ISSN:	0041-0101
DOI:	10.1016/j.toxicon.2020.11.490
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d4d67efb76c4cba5c2f9674b04a92e9b https://doi.org/10.1016/j.toxicon.2020.11.490 Zobrazit plný text záznamu Full Text from ScienceDirect